Drug shortages in health care institutions: perspectives in early 2014.

@article{Barthlmy2014DrugSI,
  title={Drug shortages in health care institutions: perspectives in early 2014.},
  author={Isabelle Barth{\'e}l{\'e}my and Denis Lebel and Jean-François Bussi{\`e}res},
  journal={The Canadian journal of hospital pharmacy},
  year={2014},
  volume={67 5},
  pages={
          387-9
        }
}
The year 2012 was marked by an unprecedented number of drug shortages in Canada. This crisis was due in particular to the publication, in November 2011, of a warning letter from the US Food and Drug Administration (FDA) to Novartis International AG for its Boucherville plant, which was managed by Sandoz Canada.1,2 Although Sandoz was not the only drug manufacturer with shortages for some products, the wide range of single-source generic parenteral products affected by this crisis led to a high… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 18 REFERENCES

An act to amend the Department of Health Act (disclosure of drug shortages), 2nd sess

  • C Bill
  • Parl.,
  • 2013

Dirty medicine

  • K. Eban
  • Fortune Magazine May 15 [cited Aug 27…
  • 2013

Drug shortages in health care institutions: perspectives in early

  • I Barthelemy, D Lebel, JF. Bussières
  • Can J Hosp Pharm
  • 2013

Drug shortages in health care institutions: perspectives in early

  • I Barthélémy, D Lebel, JF. Bussières
  • Can J Hosp Pharm
  • 2013

Ruptures d’approvisionnement de médicaments : une illustration de la gestion des risques en établissement de santé

  • I Barthélémy, D Lebel, S Atkinson, JF. Bussières
  • Risques Qual
  • 2013

Sandoz : médicaments en quantités limitées

  • P Breton
  • La Presse
  • 2013

Un pharmacien a créé des pénuries de médicaments pour son profit

  • P. Teisceira-Lessard
  • La Presse Aug
  • 2013

Similar Papers

Loading similar papers…